Research.Patient.info

Clinical research, explained in plain English.

Find clinical trials for your condition, understand what taking part involves, and decide whether a study might be right for you. Trusted, jargon-free information from Patient.info.

16,322 studies indexed7,480 currently recruiting

Recently added studies

Search all studies →
Recruiting

Rare AutoImmune SElf-management Programme Development

This study aims to develop a support program for people with rare autoimmune diseases like lupus and vasculitis. It asks patients and healthcare teams across the UK what kind of support is needed to help people manage their conditions and improve their quality of life.

United Kingdom
Active not recruitingPHASE2, PHASE3

DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old

This study looks at a two-drug treatment (Dolutegravir and Lamivudine) for children and young people with HIV, aged 2 to 15. It aims to see if it's as safe and effective as their current three-drug therapy.

South Africa · Spain · Thailand
Ongoing, recruitingHuman Pharmacology (Phase I)- Other

A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED PHASE I TRIAL TO INVESTIGATE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF SINGLE ASCENDING TOPICAL DOSES OF GZ21T IN HEALTHY VOLUNTEERS

This early-stage study is testing a new skin treatment, GZ21T, for sun-damaged skin (actinic keratosis). We want to find out if it's safe, how much of it gets into the body, and if people can tolerate different doses. Healthy volunteers are needed for this research.

Sweden
Ongoing, recruitingTherapeutic confirmatory (Phase III)

A Randomized, Double-blind, Placebo Controlled Phase 3 Study of Venetoclax in Combination with Azacitidine Versus Azacitidine in Treatment Naïve Subjects with Acute Myeloid Leukemia who are Ineligible for Standard Induction Therapy, Incorporating Extension Period - Continued Access for Venetoclax. (VIALE-A)

This study looks at a new treatment called venetoclax combined with an existing medicine called azacitidine for people with a type of blood cancer called Acute Myeloid Leukaemia (AML). It aims to see if this combination works better than azacitidine alone for patients who can't have standard strong chemotherapy.

Finland · Czechia · Hungary
Ongoing, recruitingTherapeutic exploratory (Phase II)

A phase II trial of Atezolizumab plus induction chemotherapy (CT) plus chemo-radiotherapy and Atezolizumab maintenance therapy in non-resectable stage IIIA-IIIB-IIIC non-small cell lung cancer (NSCLC) patients (APOLO)

This study is testing a new way to treat certain advanced non-small cell lung cancer. It combines a drug called Tecentriq with standard chemotherapy and radiotherapy to see if it can stop the cancer from growing for longer.

Spain
Recruiting

Who Fares Best With Mindfulness Meditation

This study looks at how mindfulness meditation affects different people. It aims to find out who benefits most and who might experience problems. Researchers want to understand why mindfulness works for some and not for others, especially those with past trauma or negative thinking.

Belgium · United Kingdom